Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing LossCisplatin OtotoxicityHead and Neck CancerDizzynessInner Ear Hearing LossVestibular DiseaseSquamous Cell Carcinoma of the Head and NeckDeafnessHearing Loss
Trial Locations (1)

90419

Klinikum Nuremberg, Nuremberg

All Listed Sponsors
collaborator

Klinikum Nürnberg

OTHER

lead

Simon Jäger

OTHER